Tocriscreen Epigenetics 3.0

Discontinued Product

7578 has been discontinued.

View all Tocriscreen™ Compound Libraries products.
Description: A library of 160 epigenetic compounds (100 μL, 10 mM DMSO solutions) for high throughput screening, high content screening, target validation and assay development
Datasheet
Citations (2)
Reviews

Biological Activity for Tocriscreen Epigenetics 3.0

Tocriscreen Epigenetics Library is a library of 160 epigenetic compounds (100 μL, 10 mM solutions). Contains compounds covering >40 epigenetic targets including epigenetic readers, writers, erasers and transcriptional modulators. Includes the latest chemical tools to target p300/CBP, PCAF, BRPF1 and SMYD2.

This library replaces the Tocriscreen Epigenetics Library (Cat. No. 6801).

Key Format and Product Details for Tocriscreen Epigenetics 3.0

  • 96-well racks with Matrix storage tubes & SepraSeal caps
  • Pre-dissolved in DMSO
  • Exceptional purity
  • Many compounds are exclusive to Tocris
  • Full chemical and biological data available
  • Proven solubility, biological activity and stability in DMSO
Target Classes Covered by the Tocriscreen Epigenetics Library

The Tocriscreen Epigenetics Compound Library contains bioactive compounds covering a diverse range of molecular targets within the following categories: epigenetic writers (43%), transcription modulators (23%), epigenetic erasers (19%), and epigenetic readers (16%).

Technical Data for Tocriscreen Epigenetics 3.0

Storage Store at -20°C

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for Tocriscreen Epigenetics 3.0

Certificate of Analysis is currently unavailable on-line.
Please contact Customer Service

References for Tocriscreen Epigenetics 3.0

References are publications that support the biological activity of the product.

View Related Products by Target

Keywords: Tocriscreen Epigenetics 3.0, Tocriscreen Epigenetics 3.0 supplier, Tocriscreens, Epigenetics, Library, compounds, libraries, screening, tools, histones, readers, writers, erasers, bromodomains, BET, BRD, DNA, methyltransferases, HMTs, MBT, L3MBT, RNA, polymerases, demethylases, HDMs, acetyltransferases, HATs, deacetylases, HDACS, KDMs, modulators, t, Tocriscreen, Compound, Libraries, 7578, Tocris Bioscience

2 Citations for Tocriscreen Epigenetics 3.0

Citations are publications that use Tocris products. Selected citations for Tocriscreen Epigenetics 3.0 include:

Andricovich et al (2018) Loss of KDM6A activates super-enhancers to induce gender-specific squamous-like pancreatic cancer and confers sensitivity to BET inhibitors. Cancer Cell 33 512 PMID: 29533787

Zhang et al (2023) Deciphering a global source of non-genetic heterogeneity in cancer cells. Nucleic Acids Res. 51 9019 PMID: 37587722


Reviews for Tocriscreen Epigenetics 3.0

There are currently no reviews for this product. Be the first to review Tocriscreen Epigenetics 3.0 and earn rewards!

Have you used Tocriscreen Epigenetics 3.0?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review